Publicaciones en colaboración con investigadores/as de Thomas Jefferson University (10)

2022

  1. Efficacy of niraparib by time of surgery and postoperative residual disease status: A post hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study

    Gynecologic Oncology, Vol. 166, Núm. 1, pp. 36-43

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. Integrated Multiomics Reveals Glucose Use Reprogramming and Identifies a Novel Hexokinase in Alcoholic Hepatitis

    Gastroenterology, Vol. 160, Núm. 5, pp. 1725-1740.e2

2020

  1. A Novel Mouse Model of Acute-on-Chronic Cholestatic Alcoholic Liver Disease: A Systems Biology Comparison With Human Alcoholic Hepatitis

    Alcoholism: Clinical and Experimental Research, Vol. 44, Núm. 1, pp. 87-101

  2. Hepatic lipocalin 2 promotes liver fibrosis and portal hypertension

    Scientific Reports, Vol. 10, Núm. 1

  3. Niraparib in Patients With Newly Diagnosed Advanced Ovarian Cancer

    Obstetrical and Gynecological Survey

2019

  1. Niraparib in patients with newly diagnosed advanced ovarian cancer

    New England Journal of Medicine, Vol. 381, Núm. 25, pp. 2391-2402

2017

  1. T Cell Migration from Inflamed Skin to Draining Lymph Nodes Requires Intralymphatic Crawling Supported by ICAM-1/LFA-1 Interactions

    Cell Reports, Vol. 18, Núm. 4, pp. 857-865

2011

  1. Defining the critical hurdles in cancer immunotherapy

    Journal of Translational Medicine

  2. Research reporting standards for radioembolization of hepatic malignancies

    Journal of Vascular and Interventional Radiology, Vol. 22, Núm. 3, pp. 265-278